63P-20254-96936
3 vaccinations
15 coded responses
33 check-ins
14 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 920 / CA
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Pfizer-BioNTech
-
2021-05-21
Registered in v-safe
-
2021-05-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-05-23
-
2021-05-24
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-05-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-27
-
2021-06-03
Survey response — day 14, dose 1MedDRA: Heavy menstrual bleeding — Feeling: FairFree text: Really strange bleeding with period. In fact, I don't normally get periods at all, but I've had a very long and weird one.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-10
Survey response — day 21, dose 1MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Worst asthma of my life.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Survey response — day 28, dose 1MedDRA: Abdominal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Daily abdominal painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Survey response — day 35, dose 1MedDRA: Hypoglycaemia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Hypoglycemia verified by glucose monitor. Also, free light chain ratio is off with too many free kappa chains.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Report sent to call center — day 35, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-30
- 2021-07-01
- 2021-07-01
-
2021-08-19
Survey response — 3 months, dose 1MedDRA: Nervous system disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I am having brachial plexus issues in my entire arm.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-19
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-26
Call successfulParticipant prefers to complete VAERS report online
-
2021-08-26
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-16
Dose 2 — Pfizer-BioNTech
-
2021-09-27
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-30
Survey response — day 14, dose 2MedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint painMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — day 21, dose 2MedDRA: Vaginal haemorrhage — Feeling: FairFree text: unusual vaginal bleedingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
-
2021-10-21
Survey response — day 35, dose 2MedDRA: Antiphospholipid antibodies positive, Red blood cell sedimentation rate increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Suddenly I have antiphospholipid antibodies and a high sedimentation rate.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-27
Call successfulParticipant prefers to complete VAERS report online
- 2021-10-28
-
2021-12-16
Survey response — 3 months, dose 2MedDRA: Blood homocysteine increased, Factor VIII activity increased, Hypergammaglobulinaemia benign monoclonal — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MGUS, high homocysteine, high Factor viii activity.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-16
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-18
-
2022-03-17
Survey response — 6 months, dose 2MedDRA: Undifferentiated connective tissue disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Undifferentiated connective tissue diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-03-17
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-23
-
2022-04-25
Dose 3 — Pfizer-BioNTech
-
2022-04-26
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral, Paraesthesia — Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pain and swelling in armpit and tingling down arm to fingers.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — days 1–6 daily, dose 3MedDRA: Burning sensation — Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches · Be unable to work or attend schoolFree text: Burning pain on that armMedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Joint pains, NauseaAdult check-in
-
2022-04-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-24
- 2022-05-30
- 2022-06-06
-
2022-07-26
Survey response — 3 months, dose 3MedDRA: Arthralgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Joint pain and sorenessMedDRA releases: 2024-11 · check-in free text available
-
2022-07-26
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-24
Survey response — 6 months, dose 3MedDRA: Autoimmune disorder, Hypergammaglobulinaemia benign monoclonal — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I now have an autoimmune disease and MGUS.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-25
-
2023-04-30
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-05-01
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Pfizer-BioNTech | |
| 2 | 2021-09-16 | Pfizer-BioNTech | No |
| 3 | 2022-04-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-24 | Successful 2021-08-26 |
Participant prefers to complete VAERS report online |
| 2021-08-19 | Successful 2021-08-26 |
Participant prefers to complete VAERS report online |
| 2021-10-21 | Successful 2021-10-27 |
Participant prefers to complete VAERS report online |
| 2021-12-16 | Successful 2022-07-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-03-17 | Successful 2022-07-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-07-26 | Successful 2022-07-26 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-24 | Unsuccessful | |
| 2023-04-30 | Unsuccessful |
Free text
Release 8 — day 14, dose 1
Symptoms: Really strange bleeding with period. In fact, I don't normally get periods at all, but I've had a very long and weird one.
Release 9 — day 21, dose 1
Symptoms: Worst asthma of my life.
Release 9 — day 28, dose 1
Symptoms: Daily abdominal pain
Release 9 — day 35, dose 1
Symptoms: Hypoglycemia verified by glucose monitor. Also, free light chain ratio is off with too many free kappa chains.
Release 9 — 3 months, dose 1
Symptoms: I am having brachial plexus issues in my entire arm.
Release 9 — day 14, dose 2
Symptoms: Joint pain
Release 10 — day 21, dose 2
Symptoms: unusual vaginal bleeding
Release 10 — day 35, dose 2
Symptoms: Suddenly I have antiphospholipid antibodies and a high sedimentation rate.
Release 10 — 3 months, dose 2
Symptoms: MGUS, high homocysteine, high Factor viii activity.
Release 11 — 6 months, dose 2
Symptoms: Undifferentiated connective tissue disease
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Pain and swelling in armpit and tingling down arm to fingers.
Systemic reaction (other): Burning pain on that arm
Release 12 — 3 months, dose 3
Symptoms: Joint pain and soreness
Release 12 — 6 months, dose 3
Symptoms: I now have an autoimmune disease and MGUS.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Antiphospholipid antibodies positive | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Blood homocysteine increased | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Factor VIII activity increased | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hypergammaglobulinaemia benign monoclonal | · | · | ✓ |
| SD | Hypoglycaemia | ✓ | ✓ | ✓ |
| SD | Nervous system disorder | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Red blood cell sedimentation rate increased | · | · | ✓ |
| SD | Undifferentiated connective tissue disease | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Burning sensation | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release